Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-06 Wettig Thane Chief Commercial Officer Shares withheld for taxes −360 $9.50 $3K 89,961
2022-06-01 Eisner Mark Chief Medical Officer Shares withheld for taxes −1,141 $9.61 $11K 149,800
2022-04-07 Conterno Enrique A Chief Executive Officer Shares withheld for taxes −1,311 $12.73 $17K 303,712
2022-03-31 Chung Christine SVP, China Operations Shares withheld for taxes −4,682 $12.02 $56K 245,852
2022-03-31 Eisner Mark Chief Medical Officer Shares withheld for taxes −6,442 $12.02 $77K 150,941
2022-03-22 Wettig Thane Chief Commercial Officer Shares withheld for taxes −655 $13.31 $9K 90,321
2022-03-07 Wettig Thane Chief Commercial Officer Shares withheld for taxes −1,706 $12.69 $22K 90,976
2022-03-07 Chung Christine SVP, China Operations Shares withheld for taxes −3,905 $12.69 $50K 250,534
2022-03-07 Conterno Enrique A Chief Executive Officer Shares withheld for taxes −7,081 $12.69 $90K 305,023
2022-03-01 Eisner Mark Chief Medical Officer Shares withheld for taxes −756 $13.62 $10K 157,383
2022-02-14 Wettig Thane Chief Commercial Officer Grant or award +45,000 92,682
2022-02-14 Wettig Thane Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-02-14 Graham Juan Chief Financial Officer Grant or award +22,500 58,900
2022-02-14 Graham Juan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2022-02-14 Eisner Mark Chief Medical Officer Grant or award +60,000 158,139
2022-02-14 Eisner Mark Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-02-14 Chung Christine SVP, China Operations Grant or award +45,000 254,439
2022-02-14 Chung Christine SVP, China Operations Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-02-14 Conterno Enrique A Chief Executive Officer Grant or award +179,400 312,104
2022-02-14 Conterno Enrique A Chief Executive Officer Grant or award · Stock Option (Right to Buy) +298,000 298,000

Page 13 of 16 · 320 trades